I-Mab Signs Two New Collaborations With Immorna And neoX Biotech; Both Partner Companies To Receive Undisclosed Upfront And/Or Milestone Payments
I-Mab (the "Company") (NASDAQ:IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the signing of two new